Kura Oncology (KURA) Short Interest Ratio & Short Volume → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free KURA Stock Alerts $22.17 -0.81 (-3.52%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Kura Oncology Short Interest DataCurrent Short Volume10,350,000 sharesPrevious Short Volume10,120,000 sharesChange Vs. Previous Month+2.27%Dollar Volume Sold Short$203.07 millionShort Interest Ratio / Days to Cover11.4Last Record DateApril 30, 2024Outstanding Shares76,180,000 sharesPercentage of Shares Shorted13.59%Today's Trading Volume582,334 sharesAverage Trading Volume1,218,819 sharesToday's Volume Vs. Average48% Short Selling Kura Oncology ? Sign up to receive the latest short interest report for Kura Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatKURA Short Interest Over TimeKURA Days to Cover Over TimeKURA Percentage of Float Shorted Over Time Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. Kura Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202410,350,000 shares $203.07 million +2.3%N/A11.4 $19.62 4/15/202410,120,000 shares $192.38 million -2.8%15.9%7.2 $19.01 3/31/202410,410,000 shares $222.05 million +1.1%16.4%7.4 $21.33 3/15/202410,300,000 shares $230.10 million -6.5%16.2%7.3 $22.34 2/29/202411,020,000 shares $232.30 million +4.9%17.4%7 $21.08 2/15/202410,510,000 shares $215.56 million +12.2%16.3%7.1 $20.51 Get the Latest News and Ratings for KURA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kura Oncology and its competitors with MarketBeat's FREE daily newsletter. 1/31/20249,370,000 shares $188.71 million No Change14.3%6.2 $20.14 1/15/20249,370,000 shares $144.02 million +1.2%14.3%9.4 $15.37 12/31/20239,260,000 shares $133.16 million -15.9%14.1%8.9 $14.38 12/15/202311,010,000 shares $135.42 million -0.6%16.7%11.1 $12.30 11/30/202311,080,000 shares $107.14 million +1.9%16.8%14.3 $9.67 11/15/202310,870,000 shares $101.96 million +7.6%16.5%14.5 $9.38 10/31/202310,100,000 shares $85.35 million +38.6%15.3%15.4 $8.45 10/15/20237,290,000 shares $61.53 million +4.1%11.1%11.4 $8.44 9/30/20237,000,000 shares $63.84 million +9.9%10.6%12.2 $9.12 9/15/20236,370,000 shares $63.00 million +3.8%9.7%10.3 $9.89 8/31/20236,140,000 shares $60.97 million -1.4%N/A7.8 $9.93 8/15/20236,230,000 shares $72.95 million +3.0%N/A7.2 $11.71 7/31/20236,050,000 shares $63.16 million -4.1%N/A6.8 $10.44 7/15/20236,310,000 shares $63.35 million +1.3%N/A7.1 $10.04 6/30/20236,230,000 shares $65.91 million -16.3%N/A7.2 $10.58 6/15/20237,440,000 shares $81.54 million +21.2%N/A9 $10.96 5/31/20236,140,000 shares $81.78 million -21.8%9.6%9.6 $13.32 5/15/20237,850,000 shares $99.38 million -0.4%12.4%12.5 $12.66 4/30/20237,880,000 shares $76.75 million -0.1%12.5%13.4 $9.74 4/15/20237,890,000 shares $90.26 million -3.8%12.5%12.9 $11.44 3/31/20238,200,000 shares $100.29 million +15.5%15.3%12.8 $12.23 3/15/20237,100,000 shares $83.00 million +0.1%11.0%10.6 $11.69 2/28/20237,090,000 shares $84.51 million +5.4%11.0%8.6 $11.92 2/15/20236,730,000 shares $81.37 million +1.1%10.5%8.1 $12.09 1/31/20236,660,000 shares $92.04 million +5.4%10.3%7.5 $13.82 1/15/20236,320,000 shares $90.38 million -2.5%9.8%6.2 $14.30 12/30/20226,480,000 shares $80.42 million +2.4%10.0%6.2 $12.41 12/15/20226,330,000 shares $80.39 million -11.5%9.8%5.7 $12.70 11/30/20227,150,000 shares $112.76 million +2.4%11.1%6.8 $15.77 11/15/20226,980,000 shares $106.79 million +11.0%10.8%6.9 $15.30 10/31/20226,290,000 shares $97.62 million -12.6%9.8%6.6 $15.52 10/15/20227,200,000 shares $108.79 million -3.5%11.4%8.1 $15.11 9/30/20227,460,000 shares $101.90 million -7.8%11.8%8.4 $13.66 9/15/20228,090,000 shares $118.11 million -0.4%12.8%9.5 $14.60[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. KURA Short Interest - Frequently Asked Questions What is Kura Oncology's current short interest? Short interest is the volume of Kura Oncology shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 10,350,000 shares of KURA short. Learn More on Kura Oncology's current short interest. What is a good short interest ratio for Kura Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KURA shares currently have a short interest ratio of 11.0. Learn More on Kura Oncology's short interest ratio. Which institutional investors are shorting Kura Oncology? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Kura Oncology: Walleye Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Kura Oncology's short interest increasing or decreasing? Kura Oncology saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 10,350,000 shares, an increase of 2.3% from the previous total of 10,120,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Kura Oncology's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Kura Oncology: Supernus Pharmaceuticals, Inc. (9.16%), Taro Pharmaceutical Industries Ltd. (0.68%), Spyre Therapeutics, Inc. (12.81%), Arcus Biosciences, Inc. (16.36%), Edgewise Therapeutics, Inc. (10.36%), Ligand Pharmaceuticals Incorporated (4.42%), Structure Therapeutics Inc. (10.35%), Schrödinger, Inc. (9.65%), Harmony Biosciences Holdings, Inc. (16.05%), Avadel Pharmaceuticals plc (5.30%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Kura Oncology stock? Short selling KURA is an investing strategy that aims to generate trading profit from Kura Oncology as its price is falling. KURA shares are trading down $0.81 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kura Oncology? A short squeeze for Kura Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KURA, which in turn drives the price of the stock up even further. How often is Kura Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KURA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: SUPN Short Interest Data TARO Short Interest Data SYRE Short Interest Data RCUS Short Interest Data EWTX Short Interest Data LGND Short Interest Data GPCR Short Interest Data SDGR Short Interest Data HRMY Short Interest Data AVDL Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KURA) was last updated on 5/18/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceThe Presidential candidate you should REALLY be worried aboutStansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressWhat’s Really Next for America…Porter & CompanyHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlace